Avenue Therapeutics, Inc. (ATXI)
US — Healthcare Sector
Automate Your Wheel Strategy on ATXI
With Tiblio's Option Bot, you can configure your own wheel strategy including ATXI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
About Avenue Therapeutics, Inc. (ATXI)
- IPO Date 2017-06-27
- Website https://www.avenuetx.com
- Industry Biotechnology
- CEO Alexandra MacLean
- Employees 2
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.